BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32111756)

  • 1. Successful Conversion Surgery Following Chylous Ascites After Nivolumab for Advanced Gastric Cancer.
    Toyota S; Orita H; Fukuyama Y; Motoyoshi S; Kawanami S; Maeda S; Kuramitsu E; Ichimanda M; Nagamatsu S; Nagata S; Kai S; Korenaga D; Mori M
    In Vivo; 2020; 34(2):583-585. PubMed ID: 32111756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion surgery for stage IV gastric cancer with a complete pathological response to nivolumab: a case report.
    Matsumoto R; Arigami T; Matsushita D; Okubo K; Tanaka T; Yanagita S; Sasaki K; Noda M; Kita Y; Mori S; Kurahara H; Ohtsuka T
    World J Surg Oncol; 2020 Jul; 18(1):179. PubMed ID: 32693806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligation and Fibrin Glue Spraying for Intractable Chylous Ascites after Radical Gastrectomy for Gastric Cancer: Case Report and Literature Review.
    Kakinuma D; Kanazawa Y; Matsuno K; Masuda Y; Ando F; Hagiwara N; Fujita I; Nomura T; Yoshiyuki T; Kato S; Yoshida H
    J Nippon Med Sch; 2021 Jun; 88(3):242-247. PubMed ID: 32863341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A Case of Unresectable Advanced Gastric Neuroendocrine Cell Carcinoma Treated with Nivolumab].
    Yoshioka R; Nagase H; Noguchi K; Hamabe A; Hirota M; Oshima K; Tanida T; Ogino T; Tomimaru Y; Kawase T; Noura S; Imamura H; Iwasawa T; Akagi K; Ando H; Tamura H; Adachi S; Dono K
    Gan To Kagaku Ryoho; 2018 Oct; 45(10):1530-1532. PubMed ID: 30382068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful Conversion Surgery for Stage IV Gastric Cancer after Nivolumab Monotherapy as Third-Line Chemotherapy.
    Watanabe H; Fujikawa H; Komori K; Kano K; Takahashi K; Yamada T; Inokuchi Y; Machida N; Yokose T; Rino Y; Masuda M; Ogata T; Oshima T
    Case Rep Gastroenterol; 2021; 15(2):562-567. PubMed ID: 34616257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended total gastrectomy after nivolumab for unresectable multivisceral invasive gastric cancer.
    Toyota S; Naito H; Motoyoshi S; Nakanishi R; Oki E; Orita H; Korenaga D
    Surg Case Rep; 2020 Nov; 6(1):298. PubMed ID: 33237443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A Case of Multiple Lymph Node Metastases Treated with Nivolumab after an Adrenalectomy for Solitary Adrenal Metastasis of Gastric Cancer after a Gastrectomy].
    Nakai M; Ichisawa A; Yamada T; Kimura T; Yonaiyama S; Jin H; Tokura T; Aoki K; Kawashima H; Toyoki Y; Endo M
    Gan To Kagaku Ryoho; 2019 Dec; 46(13):2434-2436. PubMed ID: 32156956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Two Cases of Advanced Gastric Cancer with Para‒Aortic Lymph Node Metastasis or Recurrence for Which Nivolumab Therapy Were Effective].
    Kidogami S; Endo S; Tamura S; Murotani M; Shigetsu K; Yoneda N; Imamura H; Mokutani Y; Kishimoto T; Hashimoto Y; Hirose H; Yoshioka S; Sasaki Y
    Gan To Kagaku Ryoho; 2021 Apr; 48(4):575-577. PubMed ID: 33976053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chylous ascites due to signet ring cell gastric adenocarcinoma.
    de Mello RA; Gregório T; Cardoso T
    Niger J Clin Pract; 2012; 15(4):487-90. PubMed ID: 23238204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A Case of Advanced Gastric Cancer Treated with Conversion Surgery followed by Nivolumab Combination Chemotherapy].
    Sekino N; Natsume T; Tanaka H; Kainuma O; Sato Y; Note H; Yoshioka T; Kamata T; Odera H; Uchiyama M; Maruyama T; Takahashi H; Hirano S
    Gan To Kagaku Ryoho; 2024 Apr; 51(4):417-420. PubMed ID: 38644309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical Resection First for Localized Gastric Adenocarcinoma: Are There Adjuvant Options?
    Elimova E; Ajani JA
    J Clin Oncol; 2015 Oct; 33(28):3085-91. PubMed ID: 26324361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of laparoscopic exploration combined with abdominal exfoliative cytology in the diagnosis and treatment of locally advanced gastric cancer].
    Ding PA; Liu Y; Guo HH; Yang PG; Tian Y; Fan LQ; Tan BB; Li Y; Zhao Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):170-176. PubMed ID: 32074798
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hyperprogressive Disease during Treatment with Nivolumab for Recurrence of Gastric Cancer].
    Takeoka T; Okada K; Matsuno H; Konishi K; Ota H; Yokoyama S; Fukunaga M; Kobayashi K
    Gan To Kagaku Ryoho; 2020 Jan; 47(1):165-167. PubMed ID: 32381893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion surgery after successful response to chemotherapy (S-1 + oxaliplatin + nivolumab) in a patient with stage IV gastric cancer with peritoneal metastasis (P1, CY1): a case report.
    Noma T; Nishi M; Takasu C; Wada Y; Yoshikawa K; Tokunaga T; Nakao T; Kashihara H; Yoshimoto T; Miyakami Y; Atsumi K; Uehara H; Shimada M
    Int Cancer Conf J; 2024 Jan; 13(1):11-16. PubMed ID: 38187176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response.
    Baettig F; Vlajnic T; Vetter M; Glatz K; Hench J; Frank S; Bihl M; Lopez R; Dobbie M; Heinzelmann-Schwarz V; Montavon C
    J Immunother Cancer; 2019 Oct; 7(1):281. PubMed ID: 31672171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A Case of Conversion Surgery after Nivolumab Monotherapy as Third-Line Therapy for Advanced Gastric Cancer].
    Nishitani A; Noma T; Sakata K; Ikeda K; Miyazaki S
    Gan To Kagaku Ryoho; 2023 Nov; 50(11):1199-1202. PubMed ID: 38056874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-Term Response of Nivolumab for Peritoneal Dissemination and Recurrent Liver Metastasis after Surgery for Perforated Gastric Cancer-A Case Report].
    Kii S; Kuratani Y; Fujiyoshi S; Shimokuni T; Nishikawa M; Koike M; Takahashi M
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1859-1861. PubMed ID: 36733023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DELIVER (JACCRO GC-08) trial: discover novel host-related immune-biomarkers for nivolumab in advanced gastric cancer.
    Sunakawa Y; Inoue E; Matoba R; Kawakami H; Sato Y; Nakajima TE; Muro K; Ichikawa W; Fujii M
    Future Oncol; 2019 Jul; 15(21):2441-2447. PubMed ID: 31140303
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful treatment with nivolumab for SMARCA4-deficient non-small cell lung carcinoma with a high tumor mutation burden: A case report.
    Naito T; Umemura S; Nakamura H; Zenke Y; Udagawa H; Kirita K; Matsumoto S; Yoh K; Niho S; Motoi N; Aokage K; Tsuboi M; Ishii G; Goto K
    Thorac Cancer; 2019 May; 10(5):1285-1288. PubMed ID: 30972962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion surgery for gastric remnant cancer with liver metastasis after nivolumab combination chemotherapy achieving pathological complete response: a case report and literature review.
    Katsumata K; Morimoto Y; Aoyama J; Yamada T; Katsuki Y; Nishiyama R; Egawa T
    Surg Case Rep; 2024 May; 10(1):107. PubMed ID: 38691201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.